The estimated Net Worth of Megan E Pace is at least $24.4 Миллион dollars as of 17 November 2014. Megan Pace owns over 33 units of Vertex Pharmaceuticals stock worth over $20,579,979 and over the last 12 years Megan sold VRTX stock worth over $3,832,563.
Megan has made over 11 trades of the Vertex Pharmaceuticals stock since 2013, according to the Form 4 filled with the SEC. Most recently Megan sold 33 units of VRTX stock worth $3,694 on 17 November 2014.
The largest trade Megan's ever made was exercising 56,486 units of Vertex Pharmaceuticals stock on 30 September 2014 worth over $3,092,044. On average, Megan trades about 6,898 units every 29 days since 2012. As of 17 November 2014 Megan still owns at least 43,350 units of Vertex Pharmaceuticals stock.
You can see the complete history of Megan Pace stock trades at the bottom of the page.
Megan's mailing address filed with the SEC is C/O VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY ST., CAMBRIDGE, MA, 02139.
Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden и Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: